🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formu...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02059915
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
The purpose of this study is to measure the effects of LiQ-NOL supplementat...
Status
Withdrawn
Location
Cincinnati Children's Hospital Medical Center
Start Date
2005-01
Trial ID
NCT00891917
Treatments Being Tested
To compare the relative bioavailability and pharmacokinetic characteristics...
Status
Completed
Location
Clinical trial center of Anam Hospital
Start Date
2012-01
Trial ID
NCT01829893
Treatments Being Tested
The objective of this study is to assess the relative bioavailability of tw...
Status
Completed
Location
Site Reference ID/Investigator# 27781
Start Date
2010-02
Trial ID
NCT01091649
The purpose of this study is to measure the pharmacokinetics (PK-how the bo...
Status
Recruiting
Location
Research Site
Start Date
2026-07-27
Trial ID
NCT07723833
This study will assess the safety, reactogenicity and immunogenicity of two...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-27
Trial ID
NCT01204658
This is a modular, phase I/ phase 1 b, open-label, multicentre study of cer...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-10-31
Trial ID
NCT02264678
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability, food...
Status
Completed
Location
Celerion, Inc.
Start Date
2024-03-13
Trial ID
NCT06299709
Treatments Being Tested
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-31
Trial ID
NCT01678677
Treatments Being Tested